Torrent Pharmaceuticals on Friday reported a 30% surge in its consolidated profit after tax at ₹591 crore for the September quarter, helped by robust sales across markets. The drug firm posted a profit after tax of ₹453 crore in the July-September period of the last fiscal. Its revenue increased to ₹3,302 crore for the second quarter against ₹2,889 crore in the year-ago period, it said.
The company said its India revenue stood at ₹1,820 crore during the period under review, up 12 per cent, led by outperformance in focus therapies. Brazil revenue stood at ₹318 crore and US sales at ₹337 crore during the second quarter, the drug maker said.
Torrent Pharma shares on Friday ended 0.7% up at ₹3,579.5 apiece on BSE.